Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Apoflex AB
AB
Active
Org 5594559501
Balladgatan 37
Business and other management consultancy activities · NACE 7020
Est. 2023
1-4 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 1,1M
EBITDA margin
41.7%
Equity ratio
37.2%
Financial strength
Net profit 2024
SEK 282K
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Key figures
Annual report 2024
Revenue
SEK 1,1M
—
EBITDA
SEK 472K
—
Net profit
SEK 282K
—
Total assets
SEK 825K
—
Equity
SEK 307K
—
Employees
—
—
Company information
Legal name
Apoflex AB
Org number
5594559501
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
7 november 2023
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Personal uthyrning inom apotek, vård och läkemedelsindustrin.
Contact
Address
Balladgatan 37
Email
dr.hth48@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in Malmö
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
SEK thousands
Item
2024
Revenue
1 133
Staff expenses
−569
EBITDA
472
Depreciation & amort.
—
EBIT
472
Net financials
0
Profit before tax
355
Tax
−73
Net profit
282
Balance sheet
SEK thousands
Item
2024
Total assets
825
Equity
307
Long-term debt
—
Short-term debt
402
Total debt
402
Financial ratios
5-year trend
EBITDA margin
41.7%
This company
15.8%
Market median
+164% vs market
2024
2024
Equity ratio
37.2%
This company
38.2%
Market median
+3% vs market
2024
2024
Return on equity
91.9%
This company
18.4%
Market median
+399% vs market
2024
2024
Net profit margin
24.9%
This company
8.1%
Market median
+207% vs market
2024
2024
Asset turnover
1.37×
This company
1.12×
Market median
+22% vs market
2024
2024
Debt / equity
1.69×
This company
0.62×
Market median
-173% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-11-07 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
HA
Hassan Alhassan
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
FA
Fatma Alhassan
Deputy Board Member
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Apoflex AB also hold positions in
0
other companies.
Person
Role here
Other companies
Hassan Alhassan
Chief Executive Officer
0 companies
Fatma Alhassan
Deputy Board Member
0 companies